GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Reflect Scientific Inc (OTCPK:RSCF) » Definitions » Cash Ratio

Reflect Scientific (Reflect Scientific) Cash Ratio : 2.14 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Reflect Scientific Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Reflect Scientific's Cash Ratio for the quarter that ended in Dec. 2023 was 2.14.

Reflect Scientific has a Cash Ratio of 2.14. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Reflect Scientific's Cash Ratio or its related term are showing as below:

RSCF' s Cash Ratio Range Over the Past 10 Years
Min: 0.19   Med: 2.4   Max: 9.21
Current: 2.14

During the past 13 years, Reflect Scientific's highest Cash Ratio was 9.21. The lowest was 0.19. And the median was 2.40.

RSCF's Cash Ratio is ranked better than
65.38% of 855 companies
in the Medical Devices & Instruments industry
Industry Median: 1.23 vs RSCF: 2.14

Reflect Scientific Cash Ratio Historical Data

The historical data trend for Reflect Scientific's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reflect Scientific Cash Ratio Chart

Reflect Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 2.65 6.09 9.21 2.14

Reflect Scientific Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.21 10.80 2.77 3.09 2.14

Competitive Comparison of Reflect Scientific's Cash Ratio

For the Medical Instruments & Supplies subindustry, Reflect Scientific's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Reflect Scientific's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Reflect Scientific's Cash Ratio falls into.



Reflect Scientific Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Reflect Scientific's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.278/0.596
=2.14

Reflect Scientific's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.278/0.596
=2.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Reflect Scientific  (OTCPK:RSCF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Reflect Scientific Cash Ratio Related Terms

Thank you for viewing the detailed overview of Reflect Scientific's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Reflect Scientific (Reflect Scientific) Business Description

Traded in Other Exchanges
N/A
Address
1266 South 1380 West, Orem, UT, USA, 84058
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The company serves a varies array of customers including hospitals and diagnostic laboratories, pharmaceutical and biotech companies, universities, government and private sector research facilities, and chemical and industrial companies. The products of the company are Cryometrix Freezers which provides energy savings and other critically important benefits to cryo-storage customers in the Life Science related industries, and detectors that serve the analytical instrumentation sector of the Life Sciences market. The company sells its products in the biotechnology, pharmaceutical, and medical industries.
Executives
Kim Boyce director, 10 percent owner, officer: President 1266 SOUTH 1380 WEST, OREM UT 84058
Keith L Merrell officer: CFO 1240 MUELLER PARK ROAD, BOUNTIFUL UT 84010
William G Moon director 1266 SOUTH 1380 WEST, OREM UT 84058
David Scott Strate officer: CFO 1270 S 1380 W, OREM UT 84058
Kevin Cooksy officer: Secretary Treasurer 3161 GRANADA DRIVE, CAMERON PARK CA 95682
Craig Morrison director 975 NORTH TERRACE DRIVE, PROVO UT 84604
Thomas A Tait director, officer: Vice President 514 AMERICAS WAY #5556, BOX ELDER SD 57719